AETHLON MEDICAL INC
Financial highlights
| Metric | FY 03/31/25 | FY 03/31/24 | FY 03/31/23 | FY 03/31/22 | FY 03/31/21 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | — | $0 | $574,245 | $294,165 | $659,104 |
| Research and development | $2.2M | $2.5M | $2.7M | $2.3M | $2.1M |
| Operating expenses | $9.3M | $12.6M | $12.5M | $10.7M | $8.6M |
| Operating income | -$9.3M | -$12.6M | -$11.9M | -$10.4M | -$7.9M |
| Interest expense | $10,109 | — | — | — | $1,580 |
| Income tax expense | $0 | $0 | $0 | $0 | $0 |
| Net income | -$13.4M | -$12.2M | -$12.0M | -$10.4M | -$7.9M |
| Balance Sheet | |||||
| Cash and equivalents | $5.5M | $5.4M | $14.5M | $17.1M | $9.9M |
| Current assets | $5.9M | $6.2M | $15.1M | $18.2M | $10.4M |
| Total assets | $7.4M | $8.2M | $17.5M | $19.4M | $10.7M |
| Current liabilities | $1.9M | $1.8M | $1.5M | $1.8M | $1.4M |
| Total liabilities | $2.2M | $2.5M | $2.4M | $2.4M | $1.4M |
| Stockholders' equity | $5.1M | $5.8M | $15.1M | $17.0M | $9.4M |
| Cash Flow Statement | |||||
| Cash from operations | -$7.6M | -$10.1M | -$10.5M | -$9.8M | -$6.8M |
| Depreciation and amortization | $339,559 | $359,057 | $240,892 | $123,685 | $39,939 |
| Stock-based compensation | $415,234 | $1.2M | $1.1M | $750,621 | $779,421 |
| Capital expenditure | $0 | $250,867 | $943,109 | $349,193 | $59,881 |
| Free cash flow | -$7.6M | -$10.4M | -$11.4M | -$10.1M | -$6.8M |
| Impairments | $0 | $0 | $0 | $0 | $0 |
Shares outstanding 1.3M · Free float 90.6%
Annual filing data through FY ended March 31, 2025; float as of July 3, 2026.